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Introduction: Recent data have shown that the risk of taking chronic opioids after 
surgery increases after about 5 days of postoperative opioid therapy. Alternatives to 
opioids are desirable, and transdermal lidocaine is one such perioperative multimodal 
agent. This review provides a summary of the perioperative studies that have examined 
transdermal lidocaine as an analgesic in the perioperative period. 
Methods: We conducted searches of PubMed and Scopus databases. Studies 
involving patients who were undergoing surgery and were given either transdermal 
lidocaine, placebo, or active comparator in the perioperative period with the primary 
endpoint of improvement in pain were included in the analysis. Only randomized 
controlled trails were included. 
Results: Overall, five out of the seven studies reported lower pain ratings in the 
lidocaine group compared to placebo. Three out of the four studies that used the mean 
visual analog scale (VAS) as primary endpoint reported that transdermal lidocaine 
decreased postoperative pain ratings at rest, which remained reduced for 6 h, 24, and 
72 h. In four studies, there was no difference in opioid consumption between treatment 
and placebo groups. 
Discussion: This review demonstrates that transdermal lidocaine may provide a 
modest improvement in pain ratings in the perioperative period, but the number of 
studies was limited and the duration of benefit is limited. Although five out of seven 
studies showed a decrease in pain ratings with transdermal lidocaine, this reduction 
was typically only observed at rest and often did not translate to decreased opioid 
consumption, making the overall clinical benefit questionable. 
 
